Evidence map›Paper›PMID 38890487›Full record

ArticleCommunications biology2024

Cognitive reserve involves decision making and is associated with left parietal and hippocampal hypertrophy in neurodegeneration.

Lorna Le Stanc, Marine Lunven, Maria Giavazzi, Agnès Sliwinski, Katia Youssov, Anne-Catherine Bachoud-Lévi, Charlotte Jacquemot

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. TACR3 variant confers resilience to aging and Alzheimer's disease.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lorna Le StancDépartement d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.ORCID 0000-0002-2511-9070
Marine LunvenDépartement d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Maria GiavazziDépartement d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Agnès SliwinskiDépartement d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Katia YoussovDépartement d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Anne-Catherine Bachoud-LéviDépartement d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.ORCID 0000-0003-3000-2210
Charlotte JacquemotDépartement d'Études Cognitives, École Normale Supérieure-PSL, Paris, France. charlotte.jacquemot@ens.psl.eu.ORCID 0000-0002-6611-0742

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-11-JSH2-006-1Agence Nationale de la Recherche (French National Research Agency) ANR-17-EURE-0017
6 · The paper itself

Abstract

Cognitive reserve is the ability to actively cope with brain deterioration and delay cognitive decline in neurodegenerative diseases. It operates by optimizing performance through differential recruitment of brain networks or alternative cognitive strategies. We investigated cognitive reserve using Huntington's disease (HD) as a genetic model of neurodegeneration to compare premanifest HD, manifest HD, and controls. Contrary to manifest HD, premanifest HD behave as controls despite neurodegeneration. By decomposing the cognitive processes underlying decision making, drift diffusion models revealed a response profile that differs progressively from controls to premanifest and manifest HD. Here, we show that cognitive reserve in premanifest HD is supported by an increased rate of evidence accumulation compensating for the abnormal increase in the amount of evidence needed to make a decision. This higher rate is associated with left superior parietal and hippocampal hypertrophy, and exhibits a bell shape over the course of disease progression, characteristic of compensation.

Indexed as

Cognitive ReserveDecision MakingHippocampusAdultFemaleHumansHuntington DiseaseHypertrophyMaleMiddle AgedNeurodegenerative DiseasesParietal Lobe

Identifiers

PMID38890487
PMCPMC11189446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.